Tolerogenic Dendritic Cell Therapy

· UMC Utrecht

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tolerogenic Dendritic Cell Therapy, covering 2022-02-23 to 2022-02-23. Get the full timeline:

Most recent: Clinical Trial Update: Tolerogenic Dendritic Cell Therapy for Rheumatoid Arthritis [Phase 1, Phase 2]